Arcontech Group PLC Result of AGM (0198S)

TIDMARC

RNS Number : 0198S

Arcontech Group PLC

27 September 2017

AorTech International plc

("AorTech"or the "Company")

Result of AGM

AorTech International plc (AIM: AOR), the biomaterials and medical device IP company, is pleased to announce that at the Annual General Meeting held today, all the resolutions were duly passed.

For further information contact:

AorTech International plc

Eddie McDaid, Chief Executive Tel: +44 (0)7802 920869

AorTech International plc

Bill Brown, Chairman Tel: +44 (0)7730 718296

finnCap Limited

Jonny Franklin-Adams / Giles Rolls Tel: +44 20 7220 0500

About AorTech:

AorTech has developed biostable, implantable polymers, including Elast-Eon(TM) and ECSil(TM) the world's leading long-term implantable co-polymers, now manufactured on their behalf by Biomerics LLC in Utah, USA. With several million implants and seven years of successful clinical use, AorTech polymers are being developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. Devices manufactured from AorTech polymers have numerous US FDA PMA approvals, 510k's, CE Marks, Australian TGA and Japanese Ministry of Health approvals.

Elast-Eon(TM) and ECSil(TM)'s biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. These polymers can be processed using conventional thermoplastic extrusion and moulding techniques. A range of materials in a variety of application-specific formulations for use in medical devices and components are available.

This information is provided by RNS

The company news service from the London Stock Exchange

END

RAGOKODBABKDBCB

(END) Dow Jones Newswires

September 27, 2017 12:23 ET (16:23 GMT)

Arcontech (LSE:ARC)
Historical Stock Chart
From Apr 2024 to May 2024